BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Huang W, Shao Q, Yang Y, Xu Z, Chen J, Zhang X, Ge X. Drp1, a potential therapeutic target for Parkinson's disease, is involved in olfactory bulb pathological alteration in the Rotenone-induced rat model. Toxicol Lett 2020;325:1-13. [PMID: 32088201 DOI: 10.1016/j.toxlet.2020.02.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Johnson AM, Ou ZA, Gordon R, Saminathan H. Environmental neurotoxicants and inflammasome activation in Parkinson's disease - A focus on the gut-brain axis. Int J Biochem Cell Biol 2021;142:106113. [PMID: 34737076 DOI: 10.1016/j.biocel.2021.106113] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang XL, Huang WM, Tang PC, Sun Y, Zhang X, Qiu L, Yu BC, Zhang XY, Hong YX, He Y, Ge XQ. Anti-inflammatory and neuroprotective effects of natural cordycepin in rotenone-induced PD models through inhibiting Drp1-mediated mitochondrial fission. Neurotoxicology 2021;84:1-13. [PMID: 33549657 DOI: 10.1016/j.neuro.2021.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mata-martínez E, Díaz-muñoz M, Vázquez-cuevas FG. Glial Cells and Brain Diseases: Inflammasomes as Relevant Pathological Entities. Front Cell Neurosci 2022;16:929529. [DOI: 10.3389/fncel.2022.929529] [Reference Citation Analysis]
4 Han S, Feng Y, Guo M, Hao Y, Sun J, Zhao Y, Dong Q, Zhao Y, Cui M. Role of OCT3 and DRP1 in the Transport of Paraquat in Astrocytes: A Mouse Study. Environ Health Perspect 2022;130:57004. [PMID: 35511227 DOI: 10.1289/EHP9505] [Reference Citation Analysis]
5 Zou X, Xie L, Wang W, Zhao G, Tian X, Chen M. FK866 alleviates cerebral pyroptosis and inflammation mediated by Drp1 in a rat cardiopulmonary resuscitation model. Int Immunopharmacol 2020;89:107032. [PMID: 33045576 DOI: 10.1016/j.intimp.2020.107032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Hu Z, Mao C, Wang H, Zhang Z, Zhang S, Luo H, Tang M, Yang J, Yuan Y, Wang Y, Liu Y, Fan L, Zhang Q, Yao D, Liu F, Schisler JC, Shi C, Xu Y. CHIP protects against MPP+/MPTP-induced damage by regulating Drp1 in two models of Parkinson's disease. Aging (Albany NY) 2021;13:1458-72. [PMID: 33472166 DOI: 10.18632/aging.202389] [Reference Citation Analysis]
7 Feng ST, Wang ZZ, Yuan YH, Wang XL, Guo ZY, Hu JH, Yan X, Chen NH, Zhang Y. Inhibition of dynamin-related protein 1 ameliorates the mitochondrial ultrastructure via PINK1 and Parkin in the mice model of Parkinson's disease. Eur J Pharmacol 2021;907:174262. [PMID: 34146589 DOI: 10.1016/j.ejphar.2021.174262] [Reference Citation Analysis]
8 Ray B, Bhat A, Mahalakshmi AM, Tuladhar S, Bishir M, Mohan SK, Veeraraghavan VP, Chandra R, Essa MM, Chidambaram SB, Sakharkar MK. Mitochondrial and Organellar Crosstalk in Parkinson's Disease. ASN Neuro 2021;13:17590914211028364. [PMID: 34304614 DOI: 10.1177/17590914211028364] [Reference Citation Analysis]
9 Liu HY, Gale JR, Reynolds IJ, Weiss JH, Aizenman E. The Multifaceted Roles of Zinc in Neuronal Mitochondrial Dysfunction. Biomedicines 2021;9:489. [PMID: 33946782 DOI: 10.3390/biomedicines9050489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]